Cortisol on circadian rhythm and its effect on cardiovascular system
NAS Mohd Azmi, N Juliana, S Azmani… - International journal of …, 2021 - mdpi.com
The synthesis and secretion of cortisol are controlled by the hypothalamic–pituitary–adrenal
axis. Cortisol exhibits a proper 24-h circadian rhythm that affects the brain, the autonomic …
axis. Cortisol exhibits a proper 24-h circadian rhythm that affects the brain, the autonomic …
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular …
Authors/Task Force Members… - European heart …, 2014 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep …, 2015 - academic.oup.com
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz… - Europace, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …
Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …
[HTML][HTML] Old and new oral anticoagulants: food, herbal medicines and drug interactions
A Di Minno, B Frigerio, G Spadarella, A Ravani… - Blood reviews, 2017 - Elsevier
The most commonly prescribed oral anticoagulants worldwide are the vitamin K antagonists
(VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important …
(VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important …
2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation …
Authors/Task Force Members, AJ Camm… - European heart …, 2012 - academic.oup.com
ESC Guidelines 2721 the outcome of disease may be favourably influenced by the thorough
application of clinical recommendations. Thus, the task of writing guidelines covers not only …
application of clinical recommendations. Thus, the task of writing guidelines covers not only …
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
S Halvorsen, D Atar, H Yang… - European heart …, 2014 - academic.oup.com
Aims The risk of stroke in patients with atrial fibrillation (AF) increases with age. In the
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
ARISTOTLE trial, apixaban when compared with warfarin reduced the rate of stroke, death …
EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
H Heidbuchel, P Verhamme, M Alings… - European heart …, 2013 - academic.oup.com
New oral anticoagulants (NOACs) are an alternative for vitamin K antagonists (VKAs) to
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
prevent stroke in patients with non-valvular atrial fibrillation (AF). Both physicians and …
Thyroid and the heart
IM Grais, JR Sowers - The American journal of medicine, 2014 - Elsevier
Thyroid hormones modulate every component of the cardiovascular system necessary for
normal cardiovascular development and function. When cardiovascular disease is present …
normal cardiovascular development and function. When cardiovascular disease is present …